Tom Lloyd, MD PhDAssociate Professor of Neurology and Neuroscience at Johns Hopkins University, Co-Director of the Johns Hopkins Myositis Center In a press conference today, President Trump discussed what the FDA was doing to accelerate approval of treatments for the novel coronavirus, COVID-19. Chloroquine, a drug that has been used since World War II to…
Continue Reading
Coronavirus disease also known as (COVID-19) is a respiratory illness that can spread from person to person. Symptoms include fever, cough, shortness of breath. The virus can lead to pneumonia in both lungs. Those who are immunosuppressed and/or elderly are particularly vulnerable to COVID-19 according to Dr. Rohit Aggarwal, Associate Professor of Medicine, Medical Director, Arthritis and…
Continue Reading
A recent article published in the Courier Newsroom discussed the challenges of caring for those with chronic illnesses and the economic and financial burdens that families face when dealing with debilitating disease. “Studies indicate that more than half of older Americans will eventually require long-term care, with the average lifetime long-term care costs for Americans…
Continue Reading
TMA is very excited to be participating again Rare Disease Week on Capitol Hill with our partner, The Every Life Foundation (February 24-29). Last year, we were able to secure 5 meetings with legislators, attended a briefing, had a tour of the clinic at NIH and lunch with NIH myositis researchers. This year looks to…
Continue Reading
The Myositis Association (TMA) is excited to announce the groundbreaking development of the first humanized mouse model for sporadic inclusion body myositis (sIBM) achieved through TMA’s innovative Pilot Research Funding Program. With the generous funding of The Myositis Association’s Pilot Research Grant, Dr. Thomas Lloyd, a member of TMA’s Medical Advisory Board, and his research…
Continue Reading